BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23615044)

  • 1. Capturing the patient's experience: using qualitative methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer.
    Williams LA; Agarwal S; Bodurka DC; Saleeba AK; Sun CC; Cleeland CS
    J Pain Symptom Manage; 2013 Dec; 46(6):837-45. PubMed ID: 23615044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer.
    Sailors MH; Bodurka DC; Gning I; Ramondetta LM; Williams LA; Mendoza TR; Agarwal S; Sun CC; Cleeland CS
    Gynecol Oncol; 2013 Aug; 130(2):323-8. PubMed ID: 23685012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory.
    Mendoza TR; Wang XS; Lu C; Palos GR; Liao Z; Mobley GM; Kapoor S; Cleeland CS
    Oncologist; 2011; 16(2):217-27. PubMed ID: 21285393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN).
    Wang XS; Shi Q; Williams LA; Cleeland CS; Garcia-Gonzalez A; Chen TY; Shahid DR; Ramirez PT; Iniesta MD; Siverand AM; Meyer LA
    Gynecol Oncol; 2019 Mar; 152(3):492-500. PubMed ID: 30876494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).
    Williams LA; Whisenant MS; Mendoza TR; Haq S; Keating KN; Cuffel B; Cleeland CS
    Qual Life Res; 2018 Dec; 27(12):3229-3241. PubMed ID: 30187393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module.
    Armstrong TS; Gning I; Mendoza TR; Vera-Bolanos E; Gilbert MR; Rhines LD; Weinberg JS; Sanchez-Williams G; Levin V; Burton AW; Cleeland C
    J Neurosurg Spine; 2010 Apr; 12(4):421-30. PubMed ID: 20367379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI).
    Wang XS; Williams LA; Eng C; Mendoza TR; Shah NA; Kirkendoll KJ; Shah PK; Trask PC; Palos GR; Cleeland CS
    Cancer; 2010 Apr; 116(8):2053-63. PubMed ID: 20166216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and Application of the MD Anderson Symptom Inventory for Traditional Chinese Medicine (MDASI-TCM).
    Li Z; Shi Q; Liu M; Jia L; He B; Yang Y; Liu J; Lin H; Lin HK; Li P; Wang XS
    J Natl Cancer Inst Monogr; 2017 Nov; 2017(52):. PubMed ID: 29140491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Italian version of the M.D. Anderson Symptom Inventory--Head and Neck Module: linguistic validation.
    Greco A; Orlandi E; Mirabile A; Takanen S; Fallai C; Iacovelli NA; Rimedio A; Russi E; Sala M; Monzani D; Rosenthal DI; Gunn GB; Steca P; Licitra L; Bossi P
    Support Care Cancer; 2015 Dec; 23(12):3465-72. PubMed ID: 25791393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group.
    Mendoza TR; Zhao F; Cleeland CS; Wagner LI; Patrick-Miller LJ; Fisch MJ
    Clin Breast Cancer; 2013 Oct; 13(5):325-34. PubMed ID: 23816985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cross-sectional Study on the Symptom Burden of Patients With Spinal Tumor: Validation of the Chinese Version of the M.D. Anderson Symptom Inventory-Spine Tumor Module.
    Xu N; Li Z; Wei F; Liu X; Jiang L; Meng N; Jiang P; Yu M; Wu F; Dang L; Zhou H; Li Y; Liu Z
    J Pain Symptom Manage; 2017 Mar; 53(3):605-613. PubMed ID: 28042067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Psychometric Evaluation of the Chinese Version of the M.D. Anderson Symptom Inventory-Heart Failure in Chinese Cancer Patients With Concurrent Heart Failure.
    Chair SY; Wang Q; Yu M; Kwok Wei So W; Tian C; Wing Hung Sit J; Mi Ling Wong E; Wing Han Chan C; Fadol A
    Rehabil Nurs; 2017; 42(6):354-361. PubMed ID: 29244037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID).
    Williams LA; Whisenant MS; Mendoza TR; Peek AE; Malveaux D; Griffin DK; Ponce DA; Granwehr BP; Sheshadri A; Hutcheson KA; Ali SM; Peterson SK; Heymach JV; Cleeland CS; Subbiah IM
    J Patient Rep Outcomes; 2023 May; 7(1):48. PubMed ID: 37237077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory Gastrointestinal Cancer Module (MDASI-GI-C).
    Chen RW; Yang SL; Xu ZY; Peng M; Chen MN; Wang QS; Chang J; Hu JL
    J Pain Symptom Manage; 2019 Apr; 57(4):820-827. PubMed ID: 30684634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy ± systemic therapy - A study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
    Viganò A; De Felice F; Iacovelli NA; Alterio D; Facchinetti N; Oneta O; Bacigalupo A; Tornari E; Ursino S; Paiar F; Caspiani O; Di Rito A; Musio D; Bossi P; Steca P; Jereczek-Fossa BA; Greco A; Orlandi E
    Oral Oncol; 2021 Apr; 115():105189. PubMed ID: 33549926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy.
    Wang XS; Srour SA; Mendoza T; Whisenant M; Subbiah I; Gonzalez E; Kamal M; Shen SE; Cleeland C; Kebriaei P; Rezvani K; Neelapu S; Ahmed S; Shpall E
    Br J Haematol; 2023 May; 201(4):738-746. PubMed ID: 36733986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module.
    Rosenthal DI; Mendoza TR; Chambers MS; Asper JA; Gning I; Kies MS; Weber RS; Lewin JS; Garden AS; Ang KK; S Wang X; Cleeland CS
    Head Neck; 2007 Oct; 29(10):923-31. PubMed ID: 17358040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and application of the Arabic version of the M. D. Anderson symptom inventory in Moroccan patients with cancer.
    Nejmi M; Wang XS; Mendoza TR; Gning I; Cleeland CS
    J Pain Symptom Manage; 2010 Jul; 40(1):75-86. PubMed ID: 20619213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What symptoms are important to patients? Developing a symptom burden measure for women with breast cancer.
    Whisenant MS; Strunk FA; Tripathy D; Williams LA
    Support Care Cancer; 2019 Dec; 27(12):4639-4647. PubMed ID: 30937601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language.
    Sánchez D; Chala A; Alvarez A; Payan C; Mendoza T; Cleeland C; Sanabria A
    J Pain Symptom Manage; 2016 Jun; 51(6):1055-61. PubMed ID: 26899822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.